{"id":"fsme-immune","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL2108699","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The vaccine works by stimulating the body's immune system to produce antibodies against the tick-borne encephalitis virus, providing long-term protection against the disease.","oneSentence":"FSME-immune is a vaccine designed to prevent tick-borne encephalitis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:33:02.352Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of tick-borne encephalitis"}]},"trialDetails":[{"nctId":"NCT04573205","phase":"PHASE4","title":"Primary TBE Vaccination for the Elderly","status":"UNKNOWN","sponsor":"Region Örebro County","startDate":"2024-01","conditions":"Tick-borne Encephalitis, Vaccine","enrollment":90},{"nctId":"NCT02318069","phase":"PHASE2, PHASE3","title":"New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly","status":"COMPLETED","sponsor":"Sormland County Council, Sweden","startDate":"2015-01","conditions":"Tick-borne Encephalitis","enrollment":250},{"nctId":"NCT02511587","phase":"PHASE4","title":"Comparison of Vaccination Routes: Subcutaneous Versus Intramuscular Application of FSME-Immun®","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2012-10","conditions":"Vaccine Efficacy","enrollment":116},{"nctId":"NCT01361776","phase":"PHASE2, PHASE3","title":"Humoral Response to Tick-borne Encephalitis Vaccine in Elderly","status":"COMPLETED","sponsor":"Sormland County Council, Sweden","startDate":"2011-09","conditions":"Tick-borne Encephalitis","enrollment":200},{"nctId":"NCT00461695","phase":"PHASE4","title":"Influence of Persistent CMV-infection on Immune Senescence","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2007-05","conditions":"Immune Senescence","enrollment":183}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"FSME-immune","genericName":"FSME-immune","companyName":"Sormland County Council, Sweden","companyId":"sormland-county-council-sweden","modality":"Biologic","firstApprovalDate":"","aiSummary":"FSME-immune is a vaccine designed to prevent tick-borne encephalitis. Used for Prevention of tick-borne encephalitis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}